Christopher Tarpey

About Christopher Tarpey

Chris Tarpey brings over 20 years’ experience in the in-vitro diagnostic field. From 2018 to 2022, Chris led Abbott Laboratories’ (NYSE: ABT) Toxicology Business Unit, heading a global team of employees. From 20••••18, Chris served as General Manager of eScreen, Inc, a leading third-party administrator of occupational health and drug screening programs in the United States. Chris was instrumental in evolving the eScreen diagnostic product portfolio, successfully positioning the organization’s electronic chain of custody form as first to market for regulated drug testing, and developing numerous strategic partnerships which further accelerated market penetration. Prior to joining eScreen, Chris served as Managing Director of Alere Toxicology plc, based in Oxfordshire, England, and held a variety of roles with Alere (NYSE: ALR), spanning sales, marketing, and business development.

Experience

1. Chief Commercial Officer (CCO)

   Nform

   May 2023 — Present · Kansas City, MO, US

Education

• Boston College

  BS, Chemistry, Economics

  1996 — 2000

Skills

• Competitive Analysis
• Start-Ups
• Strategy
• Product Development
• Management
• Team Building
• Healthcare
• Business Development
• Account Management
• Business Strategy
• Medical Devices
• Salesforce.com
• Strategic Planning
• Sales Operations
• Sales Management
• Leadership
• Key Account Management
• Product Marketing
• Cross-Functional Team Leadership
• Marketing Strategy
• Toxicology
• Product Management
• New Business Development
• Sales